Synspira Therapeutics, Inc.

About Synspira Therapeutics, Inc.

Synspira Therapeutics develops targeted therapies for cystic fibrosis and other rare diseases using rational drug design to enhance treatment efficacy. The company aims to improve patient outcomes by addressing the underlying genetic and biochemical mechanisms of these conditions.

What does Synspira Therapeutics, Inc. do?

Synspira Therapeutics develops targeted therapies for cystic fibrosis and other rare diseases using rational drug design to enhance treatment efficacy. The company aims to improve patient outcomes by addressing the underlying genetic and biochemical mechanisms of these conditions.

When was Synspira Therapeutics, Inc. founded?

Synspira Therapeutics, Inc. was founded in 2017.

How much funding has Synspira Therapeutics, Inc. raised?

Synspira Therapeutics, Inc. has raised 14000000.

Founded
2017
Funding
14000000
Employees
6 employees
Major Investors
Cystic Fibrosis Foundation

Find Investable Startups and Competitors

Search thousands of startups using natural language

Start Searching

Synspira Therapeutics, Inc.

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

Synspira Therapeutics develops targeted therapies for cystic fibrosis and other rare diseases using rational drug design to enhance treatment efficacy. The company aims to improve patient outcomes by addressing the underlying genetic and biochemical mechanisms of these conditions.

synspira.com500+
cb
Crunchbase
Founded 2017

Funding

$

Estimated Funding

$10M+

Major Investors

Cystic Fibrosis Foundation

Team (5+)

No team information available.
Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.